Roderick Wong
@Rtw Investments, Lp
Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CGEMCullinan Therapeutics Inc
| 0.42% | $28.558M 1.706M shares@ $16.74 avg price | Increased 62.07% |
TEMTempus Ai Inc
| 0.33% | $22.64M 400,000 shares@ $56.6 avg price | |
GHRSGh Research Plc
| 0.33% | $22.258M 3.327M shares@ $6.69 avg price | |
LENZLenz Therapeutics Inc
| 0.3% | $20.497M 863,389 shares@ $23.75 avg price | |
EPIXEssa Pharma Inc
| 0.29% | $19.765M 3.261M shares@ $6.07 avg price | Increased 41.89% |
TRMLTourmaline Bio Inc
| 0.28% | $19.068M 741,656 shares@ $25.72 avg price | |
DNTHDianthus Therapeutics Inc
| 0.27% | $18.253M 666,667 shares@ $27.38 avg price | |
ROIVRoivant Sciences Ltd
| 0.25% | $16.782M 1.454M shares@ $11.54 avg price | |
BIOABioage Labs Inc
| 0.24% | $16.356M 786,353 shares@ $20.8 avg price | New Position |
REPLReplimune Group Inc
| 0.18% | $12.426M 1.134M shares@ $10.97 avg price |